Article
Patient-derived xenografts (PDXs) as model systems for human cancer
18 Feb 2020
Abstract excerpt
Patient-derived xenografts (PDXs) are obtained by transplanting fragments of a patient's tumour into immunodeficient mice. Growth and propagation of PDXs allows correlating therapeutic response in vivo with extensive, multi-dimensional molecular annotation, leading to identification of predictive biomarkers. PDXs are increasingly recognised as clinically relevant models of cancer for several reasons, of which the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
